Live Quote · NASDAQEMBCHealthcare· Drug Manufacturers - Specialty & Generic

Embecta Corp.

$3.35 0.30%($-0.01)
TickerSpark Score
66/100
Solid
100
Valuation
75
Profitability
55
Growth
72
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EMBC research report →

52-Week Range5% of range
Low
$2.77
Current
$3.35
High
$15.55
Company Overviewwww.embecta.com

About the company

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices.

CEO
Devdatt Kurdikar
IPO
2022
Employees
2,000
HQ
Parsippany, NJ, US

Price Chart

-67.32% · this period
$15.31$9.11$2.90Jul 02Dec 31Jul 02
Valuation
Market Cap
$198.75M
P/E
1.75
P/S
0.19
P/B
-0.31
EV/EBITDA
4.26
Div Yield
13.73%
Profitability
Gross Margin
62.52%
Op Margin
29.78%
Net Margin
10.73%
ROE
-17.48%
ROIC
25.77%
Growth & Income
Revenue
$1.08B · -3.80%
Net Income
$95.40M · 21.84%
EPS
$1.64 · 20.59%
Op Income
$329.30M
FCF YoY
816.58%
Performance & Tape
52W High
$15.55
52W Low
$2.77
50D MA
$4.33
200D MA
$9.92
Beta
0.81
Avg Volume
2.38M

Get TickerSpark's AI analysis on EMBC

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 1, 26Roth Anthony M.other30,000
Feb 11, 26Anderson Carrie Lother22,841
Feb 11, 26HOMBACH ROBERT J.other22,841
Feb 11, 26Morris Milton Mayoother22,841
Feb 11, 26Prange Karenother22,841
Feb 11, 26Pomeroy Claireother22,841
Feb 11, 26Reidy Christopher Rother22,841
Nov 26, 25Mann Jeffrey Zother0
Nov 26, 25Elguicze Jacobother0
Nov 26, 25Roth Anthony M.other32,817
Coverage · EMBC

Our EMBC coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on EMBC yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate EMBC report →
Internal Compare

Similar companies

Peers in the same neighborhood.